SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-001540
Filing Date
2018-02-07
Accepted
2018-02-07 16:42:01
Documents
3
Period of Report
2018-02-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K WOLFF APPOINTMENT snss-8k_20180202.htm 8-K 36431
2 EX-99.1 PRESS RELEASE DATED FEBRUARY 7, 2018. snss-ex991_14.htm EX-99.1 14822
3 GRAPHIC g2018020718125808868872.jpg GRAPHIC 2773
  Complete submission text file 0001564590-18-001540.txt   56617
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 18581631
SIC: 2834 Pharmaceutical Preparations